April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Galectin Expression Signature in Normal and Neovascularized Corneas
Author Affiliations & Notes
  • Satoshi Sugaya
    Ophthalmology, Tufts University school of medicine, Boston, MA
  • Wei-Sheng Chen
    Sackler School of Graduate Biomedical Sciences, Tufts University school of medicine, Boston, MA
  • Zhiyi Cao
    Ophthalmology, Tufts University school of medicine, Boston, MA
  • Kenneth R Kenyon
    Ophthalmology, Tufts University school of medicine, Boston, MA
  • Noorjahan A Panjwani
    Ophthalmology, Tufts University school of medicine, Boston, MA
    Sackler School of Graduate Biomedical Sciences, Tufts University school of medicine, Boston, MA
  • Footnotes
    Commercial Relationships Satoshi Sugaya, None; Wei-Sheng Chen, None; Zhiyi Cao, None; Kenneth Kenyon, None; Noorjahan Panjwani, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 4705. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Satoshi Sugaya, Wei-Sheng Chen, Zhiyi Cao, Kenneth R Kenyon, Noorjahan A Panjwani; Galectin Expression Signature in Normal and Neovascularized Corneas. Invest. Ophthalmol. Vis. Sci. 2014;55(13):4705.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Galectins constitute a family of widely distributed carbohydrate-binding proteins characterized by their affinity for β-galactoside-containing glycans found on many cell surface and extracellular matrix glycoprotein. In mammals, there are currently 15 members of the galectin family. There is currently intense interest in characterizing the function of galectins because so many important cellular responses such as cell adhesion, migration, immune response and angiogenesis are regulated by this class of lectins. The goal of the current study was to determine the integrated portrait of galectin network in normal and neovascularized corneas.

Methods: Corneal neovascularization was induced by silver nitrate cautery. Briefly, a silver nitrate applicator was placed on the surface of the cornea for 5s and then corneas were rinsed extensively with PBS. One week after cauterization, corneas were harvested and subjected to Western blot analysis using a panel of anti-galectin antibodies. Specificity of antibodies was verified using various recombinant galectins.

Results: Blood vessels were seen entering the cornea within 2 to 3 days following cauterization. Peak blood vessel density was detected around day 7. In both normal and neovascularized corneas, galectins-1, -3, -7 -8 and -9 were detected. Initial studies suggest that in neovascularized corneas, galectin-7 is markedly upregulated whereas galectin-9 is downregulated. Studies are in progress to verify these findings by QPCR and immunohistochemistry.

Conclusions: Considering that galectins identified in the corneas are well-known for their role in immune privilege (galectins-1 and -9) and neovascularization (galectins -1, and -3), findings presented in this abstract lays foundation for studies aimed at identifying novel targets to inhibit corneal neovascularization and promote graft survival.

Keywords: 765 wound healing • 541 glycoconjugates/glycoproteins • 480 cornea: basic science  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×